Research into areas like cancer could become collateral damage of a broader anti-mRNA push, according to a new study.

The Covid-19 pandemic delivered many lessons across the world, especially in relation to fragile supply chains. Some of these ...

A new study has found that receiving messenger RNA-based COVID-19 vaccines such as those from Pfizer (NYSE:PFE)/BioNTech (NASDAQ:BNTX) and Moderna (NASDAQ:MRNA) could boost the survival rates of ...

A single oral antiviral that works against common colds, influenza, COVID-19, and other respiratory infections sounds like ...

As the world marks World Immunization Week, attention turns once again to the lifesaving power of vaccines. Amid headlines about rising cases of measles, falling vaccination rates and growing vaccine ...

The coronavirus disease 2019 (COVID-19) pandemic took a heavy toll on human life and health beginning in 2020. Though the severity of the pandemic has faded, its long-term sequelae continue to plague ...

Katalin Karikó, a Nobel Prize-winning scientist who pioneered mRNA research that led to life-saving vaccines during the COVID ...

The technology, called the Viral-Engineered RNA-based Activation System (VERAS), hijacks the virus’s own replication machinery to switch on reporter or therapeutic genes precisely in infected cells.

"Yes, the current vaccine offers significant protection against serious illness from all currently circulating COVID strains, ...